Annual Net Income
-$31.39 M
+$20.27 M+39.25%
December 31, 2023
Summary
- As of March 15, 2025, QNCX annual net profit is -$31.39 million, with the most recent change of +$20.27 million (+39.25%) on December 31, 2023.
- During the last 3 years, QNCX annual net income has risen by +$45.46 million (+59.16%).
- QNCX annual net income is now -156.52% below its all-time high of -$12.23 million, reached on December 31, 2017.
Performance
QNCX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$5.49 M
+$22.24 M+80.19%
September 30, 2024
Summary
- As of March 15, 2025, QNCX quarterly net profit is -$5.49 million, with the most recent change of +$22.24 million (+80.19%) on September 30, 2024.
- Over the past year, QNCX quarterly net income has increased by +$3.40 million (+38.25%).
- QNCX quarterly net income is now -117.85% below its all-time high of -$2.52 million, reached on September 30, 2018.
Performance
QNCX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$53.26 M
-$141.00 K-0.27%
September 30, 2024
Summary
- As of March 15, 2025, QNCX TTM net profit is -$53.26 million, with the most recent change of -$141.00 thousand (-0.27%) on September 30, 2024.
- Over the past year, QNCX TTM net income has dropped by -$21.88 million (-69.71%).
- QNCX TTM net income is now -1477.26% below its all-time high of -$3.38 million, reached on March 31, 2018.
Performance
QNCX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
QNCX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.3% | +38.3% | -69.7% |
| 3 y3 years | +59.2% | +38.3% | -69.7% |
| 5 y5 years | -151.6% | +38.3% | -69.7% |
QNCX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +65.1% | -12.4% | +80.2% | -90.1% | +40.8% |
| 5 y | 5-year | at high | +65.1% | -12.4% | +80.2% | -90.1% | +40.8% |
| alltime | all time | -156.5% | +65.1% | -117.8% | +80.2% | -1477.3% | +40.8% |
Quince Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.49 M(-80.2%) | -$53.26 M(+0.3%) |
| Jun 2024 | - | -$27.73 M(+148.7%) | -$53.12 M(+75.4%) |
| Mar 2024 | - | -$11.15 M(+25.4%) | -$30.28 M(-3.5%) |
| Dec 2023 | -$31.39 M(-39.2%) | -$8.89 M(+66.2%) | -$31.39 M(+12.0%) |
| Sep 2023 | - | -$5.35 M(+9.5%) | -$28.02 M(-8.4%) |
| Jun 2023 | - | -$4.89 M(-60.1%) | -$30.59 M(-27.6%) |
| Mar 2023 | - | -$12.25 M(+121.4%) | -$42.27 M(-18.2%) |
| Dec 2022 | -$51.66 M(-42.6%) | -$5.53 M(-30.1%) | -$51.66 M(-25.7%) |
| Sep 2022 | - | -$7.92 M(-52.2%) | -$69.53 M(-16.5%) |
| Jun 2022 | - | -$16.56 M(-23.5%) | -$83.31 M(-5.9%) |
| Mar 2022 | - | -$21.64 M(-7.5%) | -$88.50 M(-1.6%) |
| Dec 2021 | -$89.94 M | -$23.40 M(+7.8%) | -$89.94 M(+3.3%) |
| Sep 2021 | - | -$21.71 M(-0.2%) | -$87.10 M(+0.2%) |
| Jun 2021 | - | -$21.75 M(-5.8%) | -$86.90 M(+5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$23.09 M(+12.3%) | -$82.76 M(+7.7%) |
| Dec 2020 | -$76.85 M(+107.8%) | -$20.55 M(-4.4%) | -$76.85 M(+11.9%) |
| Sep 2020 | - | -$21.51 M(+22.1%) | -$68.67 M(+20.4%) |
| Jun 2020 | - | -$17.61 M(+2.5%) | -$57.02 M(+17.6%) |
| Mar 2020 | - | -$17.18 M(+38.8%) | -$48.48 M(+31.1%) |
| Dec 2019 | -$36.98 M(+196.4%) | -$12.38 M(+25.6%) | -$36.98 M(+31.7%) |
| Sep 2019 | - | -$9.86 M(+8.8%) | -$28.07 M(+35.4%) |
| Jun 2019 | - | -$9.06 M(+59.5%) | -$20.73 M(+40.3%) |
| Mar 2019 | - | -$5.68 M(+63.7%) | -$14.78 M(+18.5%) |
| Dec 2018 | -$12.48 M(+2.0%) | -$3.47 M(+37.6%) | -$12.48 M(+38.5%) |
| Sep 2018 | - | -$2.52 M(-18.9%) | -$9.01 M(+38.9%) |
| Jun 2018 | - | -$3.11 M(-8.0%) | -$6.49 M(+92.0%) |
| Mar 2018 | - | -$3.38 M | -$3.38 M |
| Dec 2017 | -$12.23 M | - | - |
FAQ
- What is Quince Therapeutics annual net profit?
- What is the all time high annual net income for Quince Therapeutics?
- What is Quince Therapeutics annual net income year-on-year change?
- What is Quince Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Quince Therapeutics?
- What is Quince Therapeutics quarterly net income year-on-year change?
- What is Quince Therapeutics TTM net profit?
- What is the all time high TTM net income for Quince Therapeutics?
- What is Quince Therapeutics TTM net income year-on-year change?
What is Quince Therapeutics annual net profit?
The current annual net income of QNCX is -$31.39 M
What is the all time high annual net income for Quince Therapeutics?
Quince Therapeutics all-time high annual net profit is -$12.23 M
What is Quince Therapeutics annual net income year-on-year change?
Over the past year, QNCX annual net profit has changed by +$20.27 M (+39.25%)
What is Quince Therapeutics quarterly net profit?
The current quarterly net income of QNCX is -$5.49 M
What is the all time high quarterly net income for Quince Therapeutics?
Quince Therapeutics all-time high quarterly net profit is -$2.52 M
What is Quince Therapeutics quarterly net income year-on-year change?
Over the past year, QNCX quarterly net profit has changed by +$3.40 M (+38.25%)
What is Quince Therapeutics TTM net profit?
The current TTM net income of QNCX is -$53.26 M
What is the all time high TTM net income for Quince Therapeutics?
Quince Therapeutics all-time high TTM net profit is -$3.38 M
What is Quince Therapeutics TTM net income year-on-year change?
Over the past year, QNCX TTM net profit has changed by -$21.88 M (-69.71%)